formaldehyde has been researched along with Colonic Neoplasms in 73 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
Colonic Neoplasms: Tumors or cancer of the COLON.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Case 2: A 64-year-old man with stage IV colon cancer (multiple para-aortic lymph node metastases and direct abdominal wall invasion) underwent non-curative surgery in May 2006." | 1.46 | Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports. ( Imaoka, Y; Kuranishi, F; Miyazaki, T; Ohno, T; Yasuda, H, 2017) |
| "Fifteen colon cancer tissues were collected, divided into two mirrored samples and either formalin fixed (FFPE) or PAXgene fixed (PFPE) before paraffin embedding." | 1.40 | Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial. ( Asslaber, M; Babaryka, G; Becker, I; Becker, KF; Bodó, K; Carneiro, F; Ciniselli, CM; den Bakker, M; den Hollander, J; Drecoll, E; Esposito, I; Fend, F; Gündisch, S; Höfler, H; Kap, M; Kayser, G; Langer, R; Lopes, JM; Lugli, A; May, AM; Neumann, J; Perren, A; Pizzamiglio, S; Reu, S; Richter, T; Riegman, P; Schott, C; Slotta-Huspenina, J; Sobin, L; Specht, K; Verderio, P; Viertler, C; Zatloukal, K, 2014) |
| "Its expression in colon cancer cells and metastases is conserved." | 1.36 | Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer. ( Beaudry, G; Beaulieu, M; Bertrand, N; Desaulniers, M; Deschesnes, RG; Garon, G; Haince, JF; Holzer, TJ; Houde, M, 2010) |
| "In view of recent findings of nasal cancer in rats exposed to formaldehyde vapors, we investigated the proportionate mortality experience of embalmers licensed to practice in New York State." | 1.27 | Mortality patterns among embalmers. ( Fraumeni, JF; Walrath, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (13.70) | 18.7374 |
| 1990's | 12 (16.44) | 18.2507 |
| 2000's | 18 (24.66) | 29.6817 |
| 2010's | 31 (42.47) | 24.3611 |
| 2020's | 2 (2.74) | 2.80 |
| Authors | Studies |
|---|---|
| Patil, S | 1 |
| Lis, LG | 1 |
| Schumacher, RJ | 1 |
| Norris, BJ | 1 |
| Morgan, ML | 1 |
| Cuellar, RA | 1 |
| Blazar, BR | 1 |
| Suryanarayanan, R | 1 |
| Gurvich, VJ | 1 |
| Georg, GI | 1 |
| Burns, JA | 1 |
| Li, Y | 1 |
| Cheney, CA | 1 |
| Ou, Y | 1 |
| Franlin-Pfeifer, LL | 1 |
| Kuklin, N | 1 |
| Zhang, ZQ | 1 |
| Okubo, A | 1 |
| Sone, S | 1 |
| Tanaka, M | 1 |
| Ogura, T | 1 |
| Dias, AR | 1 |
| Pereira, MA | 1 |
| Mello, ES | 1 |
| Cecconello, I | 1 |
| Ribeiro-Jr, U | 1 |
| Nahas, SC | 1 |
| Pessanha, S | 1 |
| Braga, D | 1 |
| Ensina, A | 1 |
| Silva, J | 1 |
| Vilchez, J | 1 |
| Montenegro, C | 1 |
| Barbosa, S | 1 |
| Carvalho, ML | 1 |
| Dias, A | 1 |
| Lazarus, J | 1 |
| Akiska, Y | 1 |
| Perusina Lanfranca, M | 1 |
| Delrosario, L | 1 |
| Sun, L | 1 |
| Long, D | 1 |
| Shi, J | 1 |
| Crawford, H | 1 |
| Di Magliano, MP | 1 |
| Zou, W | 1 |
| Frankel, T | 1 |
| Imaoka, Y | 1 |
| Kuranishi, F | 1 |
| Miyazaki, T | 1 |
| Yasuda, H | 1 |
| Ohno, T | 1 |
| Bonnet, E | 1 |
| Moutet, ML | 1 |
| Baulard, C | 1 |
| Bacq-Daian, D | 1 |
| Sandron, F | 1 |
| Mesrob, L | 1 |
| Fin, B | 1 |
| Delépine, M | 1 |
| Palomares, MA | 1 |
| Jubin, C | 1 |
| Blanché, H | 1 |
| Meyer, V | 1 |
| Boland, A | 1 |
| Olaso, R | 1 |
| Deleuze, JF | 1 |
| Mathieson, W | 1 |
| Mommaerts, K | 1 |
| Trouet, JM | 1 |
| Mathay, C | 1 |
| Guan, P | 1 |
| Carithers, LJ | 1 |
| Rohrer, D | 1 |
| Valley, DR | 1 |
| Blanski, A | 1 |
| Jewell, S | 1 |
| Moore, HM | 1 |
| Betsou, F | 1 |
| Gerdes, MJ | 2 |
| Sevinsky, CJ | 1 |
| Sood, A | 1 |
| Adak, S | 1 |
| Bello, MO | 1 |
| Bordwell, A | 1 |
| Can, A | 1 |
| Corwin, A | 1 |
| Dinn, S | 1 |
| Filkins, RJ | 1 |
| Hollman, D | 1 |
| Kamath, V | 1 |
| Kaanumalle, S | 1 |
| Kenny, K | 1 |
| Larsen, M | 1 |
| Lazare, M | 1 |
| Li, Q | 1 |
| Lowes, C | 1 |
| McCulloch, CC | 1 |
| McDonough, E | 1 |
| Montalto, MC | 1 |
| Pang, Z | 1 |
| Rittscher, J | 1 |
| Santamaria-Pang, A | 1 |
| Sarachan, BD | 1 |
| Seel, ML | 1 |
| Seppo, A | 1 |
| Shaikh, K | 1 |
| Sui, Y | 1 |
| Zhang, J | 1 |
| Ginty, F | 1 |
| Oue, N | 1 |
| Anami, K | 1 |
| Schetter, AJ | 1 |
| Moehler, M | 1 |
| Okayama, H | 1 |
| Khan, MA | 1 |
| Bowman, ED | 1 |
| Mueller, A | 1 |
| Schad, A | 1 |
| Shimomura, M | 1 |
| Hinoi, T | 1 |
| Aoyagi, K | 1 |
| Sasaki, H | 1 |
| Okajima, M | 1 |
| Ohdan, H | 1 |
| Galle, PR | 1 |
| Yasui, W | 1 |
| Harris, CC | 1 |
| Schubert, W | 1 |
| Dress, A | 1 |
| Ruonala, M | 1 |
| Krusche, A | 1 |
| Hillert, R | 1 |
| Gieseler, A | 1 |
| Walden, P | 1 |
| Warford, A | 1 |
| Akbar, H | 1 |
| Riberio, D | 1 |
| Plamadeala, V | 1 |
| Huang, S | 1 |
| McCreary, SM | 1 |
| Reitze, NJ | 1 |
| Ewing, AL | 1 |
| Gabrin, MJ | 1 |
| Bennett, AE | 1 |
| Mulligan, JM | 2 |
| Wilson, CL | 1 |
| Wang, D | 1 |
| Gündisch, S | 2 |
| Slotta-Huspenina, J | 1 |
| Verderio, P | 1 |
| Ciniselli, CM | 1 |
| Pizzamiglio, S | 1 |
| Schott, C | 2 |
| Drecoll, E | 1 |
| Viertler, C | 2 |
| Zatloukal, K | 2 |
| Kap, M | 2 |
| Riegman, P | 2 |
| Esposito, I | 1 |
| Specht, K | 1 |
| Babaryka, G | 1 |
| Asslaber, M | 1 |
| Bodó, K | 1 |
| den Bakker, M | 1 |
| den Hollander, J | 1 |
| Fend, F | 1 |
| Neumann, J | 1 |
| Reu, S | 1 |
| Perren, A | 1 |
| Langer, R | 2 |
| Lugli, A | 1 |
| Becker, I | 1 |
| Richter, T | 1 |
| Kayser, G | 1 |
| May, AM | 1 |
| Carneiro, F | 1 |
| Lopes, JM | 1 |
| Sobin, L | 1 |
| Höfler, H | 1 |
| Becker, KF | 2 |
| Di Narzo, AF | 1 |
| Tejpar, S | 2 |
| Rossi, S | 1 |
| Yan, P | 1 |
| Popovici, V | 1 |
| Wirapati, P | 1 |
| Budinska, E | 1 |
| Xie, T | 1 |
| Estrella, H | 1 |
| Pavlicek, A | 1 |
| Mao, M | 1 |
| Martin, E | 1 |
| Scott, W | 1 |
| Bosman, FT | 3 |
| Roth, A | 1 |
| Delorenzi, M | 1 |
| Kong, H | 1 |
| Zhu, M | 1 |
| Cui, F | 1 |
| Wang, S | 1 |
| Gao, X | 1 |
| Lu, S | 1 |
| Wu, Y | 1 |
| Zhu, H | 1 |
| Buck, A | 1 |
| Balluff, B | 1 |
| Voss, A | 1 |
| Zitzelsberger, H | 1 |
| Aichler, M | 1 |
| Walch, A | 1 |
| Norderval, S | 1 |
| Solstad, ØB | 1 |
| Hermansen, M | 1 |
| Steigen, SE | 1 |
| Chen, X | 1 |
| Deane, NG | 1 |
| Lewis, KB | 1 |
| Li, J | 2 |
| Zhu, J | 1 |
| Washington, MK | 2 |
| Beauchamp, RD | 1 |
| Cederbye, CN | 1 |
| Palshof, JA | 1 |
| Hansen, TP | 1 |
| Duun-Henriksen, AK | 1 |
| Linnemann, D | 1 |
| Stenvang, J | 1 |
| Nielsen, DL | 1 |
| Brünner, N | 1 |
| Viuff, BM | 1 |
| Lee, HM | 1 |
| Kim, CW | 1 |
| Hwang, KA | 1 |
| Choi, DW | 1 |
| Choi, KC | 1 |
| Carlson, GE | 1 |
| Martin, EW | 1 |
| Shirure, VS | 1 |
| Malgor, R | 1 |
| Resto, VA | 1 |
| Goetz, DJ | 1 |
| Burdick, MM | 1 |
| Khanmohammadi, M | 1 |
| Garmarudi, AB | 1 |
| Ghasemi, K | 1 |
| Jaliseh, HK | 1 |
| Kaviani, A | 1 |
| Bodo, J | 1 |
| Durkin, L | 1 |
| Hsi, ED | 1 |
| Constantinou, P | 1 |
| Dacosta, RS | 1 |
| Wilson, BC | 1 |
| Dufort, S | 1 |
| Richard, MJ | 1 |
| de Fraipont, F | 1 |
| Sprung, RW | 1 |
| Brock, JW | 1 |
| Tanksley, JP | 1 |
| Li, M | 1 |
| Slebos, RJ | 1 |
| Liebler, DC | 1 |
| Roberts, L | 1 |
| Bowers, J | 1 |
| Sensinger, K | 1 |
| Lisowski, A | 1 |
| Getts, R | 1 |
| Anderson, MG | 1 |
| Franklin, WA | 1 |
| Haney, J | 1 |
| Sugita, M | 1 |
| Bemis, L | 1 |
| Jimeno, A | 1 |
| Messersmith, WA | 1 |
| Beaulieu, M | 1 |
| Desaulniers, M | 1 |
| Bertrand, N | 1 |
| Deschesnes, RG | 1 |
| Beaudry, G | 1 |
| Garon, G | 1 |
| Haince, JF | 1 |
| Houde, M | 1 |
| Holzer, TJ | 1 |
| Denouël, A | 1 |
| Boissière-Michot, F | 1 |
| Rochaix, P | 1 |
| Bibeau, F | 1 |
| Boulle, N | 1 |
| Wiśniewski, JR | 1 |
| Ostasiewicz, P | 1 |
| Mann, M | 1 |
| Oltedal, S | 1 |
| Aasprong, OG | 1 |
| Møller, JH | 1 |
| Kørner, H | 1 |
| Gilje, B | 1 |
| Tjensvoll, K | 1 |
| Birkemeyer, EM | 1 |
| Heikkilä, R | 1 |
| Smaaland, R | 1 |
| Nordgård, O | 1 |
| Rodríguez-Rigueiro, T | 1 |
| Valladares-Ayerbes, M | 1 |
| Haz-Conde, M | 1 |
| Blanco, M | 1 |
| Aparicio, G | 1 |
| Fernández-Puente, P | 1 |
| Blanco, FJ | 1 |
| Lorenzo, MJ | 1 |
| Aparicio, LA | 1 |
| Figueroa, A | 1 |
| Kennedy, RD | 1 |
| Bylesjo, M | 1 |
| Kerr, P | 1 |
| Davison, T | 1 |
| Black, JM | 1 |
| Kay, EW | 1 |
| Holt, RJ | 1 |
| Proutski, V | 1 |
| Ahdesmaki, M | 1 |
| Farztdinov, V | 1 |
| Goffard, N | 1 |
| Hey, P | 1 |
| McDyer, F | 1 |
| Mulligan, K | 1 |
| Mussen, J | 1 |
| O'Brien, E | 1 |
| Oliver, G | 1 |
| Walker, SM | 1 |
| Wilson, C | 1 |
| Winter, A | 1 |
| O'Donoghue, D | 1 |
| Mulcahy, H | 1 |
| O'Sullivan, J | 1 |
| Sheahan, K | 1 |
| Hyland, J | 1 |
| Dhir, R | 1 |
| Bathe, OF | 1 |
| Winqvist, O | 1 |
| Manne, U | 1 |
| Shanmugam, C | 1 |
| Ramaswamy, S | 1 |
| Leon, EJ | 1 |
| Smith, WI | 1 |
| McDermott, U | 1 |
| Wilson, RH | 1 |
| Longley, D | 1 |
| Marshall, J | 1 |
| Cummins, R | 1 |
| Sargent, DJ | 1 |
| Johnston, PG | 1 |
| Harkin, DP | 1 |
| Krijgsman, O | 1 |
| Israeli, D | 1 |
| Haan, JC | 1 |
| van Essen, HF | 1 |
| Smeets, SJ | 1 |
| Eijk, PP | 1 |
| Steenbergen, RD | 1 |
| Kok, K | 1 |
| Meijer, GA | 1 |
| Ylstra, B | 1 |
| Adams, MD | 1 |
| Veigl, ML | 1 |
| Wang, Z | 1 |
| Molyneux, N | 1 |
| Sun, S | 1 |
| Guda, K | 1 |
| Yu, X | 1 |
| Markowitz, SD | 1 |
| Willis, J | 1 |
| Zhang, JZ | 1 |
| Bryce, NS | 1 |
| Lanzirotti, A | 1 |
| Chen, CK | 1 |
| Paterson, D | 1 |
| de Jonge, MD | 1 |
| Howard, DL | 1 |
| Hambley, TW | 1 |
| Hauck, S | 1 |
| Sarioglu, H | 1 |
| Schuster, T | 1 |
| Reischauer, B | 1 |
| Rosenberg, R | 1 |
| Verhoef, C | 1 |
| Mischinger, HJ | 1 |
| Williams, SS | 1 |
| Zimmerman, RL | 1 |
| Bibbo, M | 1 |
| BARBOSANDE, C | 1 |
| Bibikova, M | 2 |
| Talantov, D | 1 |
| Chudin, E | 2 |
| Yeakley, JM | 2 |
| Chen, J | 2 |
| Doucet, D | 1 |
| Wickham, E | 2 |
| Atkins, D | 1 |
| Barker, D | 1 |
| Chee, M | 1 |
| Wang, Y | 1 |
| Fan, JB | 2 |
| Wang-Rodriguez, J | 1 |
| Wang, F | 1 |
| Mamon, H | 1 |
| Kulke, MH | 1 |
| Harris, L | 1 |
| Maher, E | 1 |
| Wang, L | 1 |
| Makrigiorgos, GM | 1 |
| Prieto, DA | 1 |
| Hood, BL | 1 |
| Darfler, MM | 1 |
| Guiel, TG | 1 |
| Lucas, DA | 1 |
| Conrads, TP | 1 |
| Veenstra, TD | 1 |
| Krizman, DB | 1 |
| Stanta, G | 1 |
| Mucelli, SP | 1 |
| Petrera, F | 1 |
| Bonin, S | 1 |
| Bussolati, G | 1 |
| Ly, E | 1 |
| Piot, O | 1 |
| Wolthuis, R | 1 |
| Durlach, A | 1 |
| Bernard, P | 1 |
| Manfait, M | 1 |
| Matsuda, A | 1 |
| Kuno, A | 1 |
| Ishida, H | 1 |
| Kawamoto, T | 1 |
| Shoda, J | 1 |
| Hirabayashi, J | 1 |
| Liebling, T | 1 |
| Rosenman, KD | 1 |
| Pastides, H | 1 |
| Griffith, RG | 1 |
| Lemeshow, S | 1 |
| Walrath, J | 1 |
| Fraumeni, JF | 1 |
| Ofner, D | 1 |
| Bankfalvi, A | 1 |
| Riehemann, K | 1 |
| Bier, B | 1 |
| Böcker, W | 1 |
| Schmid, KW | 1 |
| Terada, T | 1 |
| Shimizu, K | 1 |
| Izumi, R | 1 |
| Nakanuma, Y | 1 |
| Kim, YW | 1 |
| Lee, S | 1 |
| Park, JH | 1 |
| Yoon, TY | 1 |
| Park, YK | 1 |
| Yang, MH | 1 |
| Vissers, CJ | 1 |
| Flohil, CC | 1 |
| de Jong, AA | 1 |
| Dinjens, WN | 1 |
| Noguchi, M | 1 |
| Furuya, S | 1 |
| Takeuchi, T | 1 |
| Hirohashi, S | 1 |
| Vince, DG | 1 |
| Tbakhi, A | 1 |
| Gaddipati, A | 1 |
| Cothren, RM | 1 |
| Cornhill, JF | 1 |
| Tubbs, RR | 1 |
| Schoen, RE | 1 |
| Gerber, LD | 1 |
| Margulies, C | 1 |
| McKay, JA | 1 |
| Murray, GI | 1 |
| Keith, WN | 1 |
| McLeod, HL | 1 |
| Trézl, L | 1 |
| Hullán, L | 1 |
| Szarvas, T | 1 |
| Csiba, A | 1 |
| Szende, B | 1 |
| Hashizume, K | 1 |
| Hatanaka, Y | 1 |
| Kamihara, Y | 1 |
| Tani, Y | 1 |
| Magdinier, F | 1 |
| Wolffe, AP | 1 |
| Kim, DH | 1 |
| Hong, YK | 1 |
| Egholm, M | 1 |
| Strauss, WM | 1 |
| Grab, DJ | 1 |
| Zedeck, MS | 1 |
| Wagner, L | 1 |
| Base, W | 1 |
| Wiesholzer, M | 1 |
| Sexl, V | 1 |
| Bognar, H | 1 |
| Worman, CP | 1 |
| Moerkerk, PT | 1 |
| Kessels, HJ | 1 |
| ten Kate, J | 1 |
| de Goeij, AF | 1 |
| D'Errico, A | 1 |
| Facchini, A | 1 |
| Meliconi, R | 1 |
| Grigioni, FW | 1 |
| Ferrone, S | 1 |
| Steven, FS | 1 |
| Ali, H | 1 |
| Griffin, MM | 1 |
| Crissman, JD | 1 |
| Zarbo, RJ | 1 |
| Niebylski, CD | 1 |
| Corbett, T | 1 |
| Weaver, D | 1 |
| Herbert, DJ | 1 |
| Nishiyama, RH | 1 |
| Bagwell, CB | 1 |
| Munson, ME | 1 |
| Hitchcox, SA | 1 |
| Lovett, EJ | 1 |
| Goelz, SE | 1 |
| Hamilton, SR | 1 |
| Vogelstein, B | 1 |
| Moullé, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lymph Node Yield After Specimen Fixation With Carnoy's Solution and 10% Neutral Buffered Formaldehyde in Patients With Colorectal Cancer or Gastric Adenocarcinoma Specimens: a Randomized Trial[NCT02629315] | 130 participants (Actual) | Interventional | 2012-05-10 | Completed | |||
| Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma[NCT05313243] | Phase 2 | 43 participants (Anticipated) | Interventional | 2023-07-10 | Recruiting | ||
| Complete Pathologic Response Rectal Cancers EYSAC.1 Study[NCT03351959] | 1,000 participants (Anticipated) | Observational | 2018-01-01 | Recruiting | |||
| The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer[NCT03923335] | 287 participants (Anticipated) | Observational | 2019-04-30 | Not yet recruiting | |||
| Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma[NCT00868192] | Phase 2 | 38 participants (Actual) | Interventional | 2008-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Overall response rate = complete response + partial response~Complete response = disappearance of all target and non-target lesions and no evidence of new lesions documented by two disease assessments at least 4 weeks apart.~Partial response = at least a 30% decrease in the sum of the longest dimensions (LD) of all target measurable lesions taking as reference the baseline sum of LD. There can be non unequivocal progression of non-target lesions and no new lesions." (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 41 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: 12 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 79 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) |
|---|---|
| Pemetrexed and Bevacizumab | 25.7 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 56 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) |
|---|---|
| Pemetrexed and Bevacizumab | 7.9 |
A CA-125 response was defined as at least a 50% reduction in CA-125 levels from a pretreatment sample following guidelines described by the Gynecological Cancer Intergroup. (NCT00868192)
Timeframe: 6 months
| Intervention | participants (Number) | ||
|---|---|---|---|
| 50% CA-125 response | 75% CA-125 response | No CA-125 response | |
| Pemetrexed and Bevacizumab | 17 | 8 | 2 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) | ||
|---|---|---|---|
| Platinum-free interval of <6 months | Platinum-free interval of 6-12 months | Platinum-free interval of >12 months | |
| Pemetrexed and Bevacizumab | 16.7 | 24.9 | 28.0 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) | ||
|---|---|---|---|
| Platinum-free interval of <6 months | Platinum-free interval of 6-12 months | Platinum-free interval of >12 months | |
| Pemetrexed and Bevacizumab | 6.7 | 4.7 | 16.8 |
As measured by RECIST criteria (NCT00868192)
Timeframe: 6 months
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Complete response | Partial response | Stable disease | Progressive disease | |
| Pemetrexed and Bevacizumab | 0 | 14 | 18 | 2 |
Detailed serious adverse events and other adverse events are shown in the adverse event module of the results. (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) | ||||
|---|---|---|---|---|---|
| Grade 3/4 hematologic toxicity | Most common non-hematologic toxicity - fatigue | Grade 3 renal toxicity | Gastrointestinal toxicity | Subsequently developed hematologic malignancies | |
| Pemetrexed and Bevacizumab | 53 | 94 | 6 | 91 | 6 |
1 review available for formaldehyde and Colonic Neoplasms
| Article | Year |
|---|---|
Antigen retrieval, blocking, detection and visualisation systems in immunohistochemistry: a review and practical evaluation of tyramide and rolling circle amplification systems.
Topics: Animals; Antibodies; Antigens; Antigens, CD20; Breast Neoplasms; Colonic Neoplasms; Female; Formalde | 2014 |
1 trial available for formaldehyde and Colonic Neoplasms
| Article | Year |
|---|---|
CARNOY'S SOLUTION INCREASES LYMPH NODES COUNT IN COLON CANCER SPECIMENS WHEN COMPARED TO FORMALIN FIXATION: A RANDOMIZED TRIAL.
Topics: Acetic Acid; Adenocarcinoma; Chloroform; Colonic Neoplasms; Ethanol; Formaldehyde; Humans; Lymph Nod | 2022 |
71 other studies available for formaldehyde and Colonic Neoplasms
| Article | Year |
|---|---|
Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Colonic Neoplasms; Diterpen | 2015 |
Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues.
Topics: Animals; Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Data Interpretation, Statistical; F | 2009 |
Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cell Communication; Cell Line; Cell Membrane; Colonic Neoplasms; | 1989 |
A non-destructive X-ray fluorescence method of analysis of formalin fixed-paraffin embedded biopsied samples for biomarkers for breast and colon cancer.
Topics: Biomarkers; Colonic Neoplasms; Formaldehyde; Humans; Paraffin Embedding; Tissue Fixation; X-Rays | 2023 |
Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry.
Topics: Antibodies; Colonic Neoplasms; Fluorescent Antibody Technique; Formaldehyde; Humans; Immunohistochem | 2019 |
Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports.
Topics: Abdominal Wall; Cancer Vaccines; Colonic Neoplasms; Combined Modality Therapy; Female; Formaldehyde; | 2017 |
Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
Topics: Colon; Colonic Neoplasms; Computational Biology; Cryopreservation; DNA; DNA, Neoplasm; Exome Sequenc | 2018 |
Cold Ischemia Score: An mRNA Assay for the Detection of Extended Cold Ischemia in Formalin-Fixed, Paraffin-Embedded Tissue.
Topics: Cold Ischemia; Colonic Neoplasms; Female; Fixatives; Formaldehyde; Humans; Kidney Neoplasms; Male; N | 2019 |
Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue.
Topics: 3,3'-Diaminobenzidine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Fem | 2013 |
High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasms; Female | 2014 |
Imaging cycler microscopy.
Topics: Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Female; Formaldehyde; Humans; Microscopy, Fl | 2014 |
Reply to Schubert et al.: Regarding critique of highly multiplexed technologies.
Topics: Biomarkers, Tumor; Breast Neoplasms; Colonic Neoplasms; Female; Formaldehyde; Humans; Microscopy, Fl | 2014 |
Analytical performance of a formalin-fixed paraffin-embedded tissue-based 634-probe prognostic assay for predicting outcome of patients with stage II colon cancer.
Topics: Biomarkers, Tumor; Colonic Neoplasms; DNA, Complementary; DNA, Neoplasm; Formaldehyde; Gene Expressi | 2014 |
Evaluation of colon cancer histomorphology: a comparison between formalin and PAXgene tissue fixation by an international ring trial.
Topics: Adenocarcinoma, Mucinous; Colonic Neoplasms; Formaldehyde; Humans; Observer Variation; Paraffin Embe | 2014 |
Test of four colon cancer risk-scores in formalin fixed paraffin embedded microarray gene expression data.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Area Under Curve; Biomarkers, Tumor; Colonic Neo | 2014 |
Quantitative assessment of short amplicons in FFPE-derived long-chain RNA.
Topics: Colonic Neoplasms; Colorectal Neoplasms; Formaldehyde; Humans; Paraffin Embedding; Rectal Neoplasms; | 2014 |
How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotro
Topics: Biomarkers; Colonic Neoplasms; Esophageal Neoplasms; Formaldehyde; Fourier Analysis; Humans; Image P | 2016 |
Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer.
Topics: Chemotherapy, Adjuvant; Colonic Neoplasms; DNA; Fixatives; Formaldehyde; Humans; Immunohistochemistr | 2016 |
Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.
Topics: Colonic Neoplasms; Formaldehyde; Frozen Sections; Gene Expression Regulation, Neoplastic; Humans; Ol | 2016 |
Antibody validation and scoring guidelines for ABCG2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
Topics: Antibodies, Monoclonal, Murine-Derived; Antibody Specificity; ATP Binding Cassette Transporter, Subf | 2016 |
Three components of cigarette smoke altered the growth and apoptosis of metastatic colon cancer cells via inducing the synthesis of reactive oxygen species and endoplasmic reticulum stress.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzene; Butadienes; Cell Line, Tumor; Cell Proliferation; Co | 2016 |
Dynamic biochemical tissue analysis detects functional L-selectin ligands on colon cancer tissues.
Topics: Adenocarcinoma, Mucinous; Adenocarcinoma, Papillary; Biochemistry; Carcinoma, Signet Ring Cell; Colo | 2017 |
Diagnosis of colon cancer by attenuated total reflectance-Fourier transform infrared microspectroscopy and soft independent modeling of class analogy.
Topics: Colonic Neoplasms; Formaldehyde; Histocytochemistry; Humans; Models, Statistical; Paraffin Embedding | 2009 |
Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Calibration; Cell Line; Colonic Neoplasms; Fixatives; f | 2009 |
Extending immunofluorescence detection limits in whole paraffin-embedded formalin fixed tissues using hyperspectral confocal fluorescence imaging.
Topics: 3,3'-Diaminobenzidine; Adenocarcinoma; Animals; Antibodies, Neoplasm; Cell Nucleus; Colonic Neoplasm | 2009 |
Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.
Topics: Base Sequence; Cell Line, Tumor; Colonic Neoplasms; DNA Mutational Analysis; ErbB Receptors; Fixativ | 2009 |
Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
Topics: Adenoma; Chromatography, Liquid; Colonic Neoplasms; Fixatives; Formaldehyde; Frozen Sections; Humans | 2009 |
Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling.
Topics: Colonic Neoplasms; Formaldehyde; Freezing; Gene Expression Profiling; Humans; Lung Neoplasms; Oligon | 2009 |
KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.
Topics: Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Colonic Neoplasms; DNA; DNA Mutational | 2010 |
Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
Topics: Colonic Neoplasms; Fixatives; Formaldehyde; Guanylate Cyclase; Humans; Lymph Nodes; Paraffin Embeddi | 2010 |
An alternative fixative to formalin fixation for molecular applications: the RCL2(®)-CS100 approach.
Topics: Colonic Neoplasms; DNA; Fixatives; Formaldehyde; Frozen Sections; Humans; Immunohistochemistry; Kera | 2011 |
High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.
Topics: Biomarkers, Tumor; Carcinoembryonic Antigen; CD55 Antigens; Cell Count; Cell Line, Tumor; Chromatogr | 2011 |
Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; ErbB Receptors; Formaldehyde; Humans; Middle Aged | 2011 |
A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues.
Topics: Antigens; Biopsy; Blotting, Western; Colonic Neoplasms; Fixatives; Formaldehyde; Humans; Immunohisto | 2011 |
Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue.
Topics: Aged; Colonic Neoplasms; Female; Formaldehyde; Gene Expression Profiling; Humans; Male; Middle Aged; | 2011 |
CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material.
Topics: Colonic Neoplasms; Comparative Genomic Hybridization; DNA; DNA Copy Number Variations; DNA, Neoplasm | 2012 |
Global mutational profiling of formalin-fixed human colon cancers from a pathology archive.
Topics: Adenocarcinoma; Biological Specimen Banks; Colonic Neoplasms; DNA, Neoplasm; Feasibility Studies; Fo | 2012 |
Getting to the core of platinum drug bio-distributions: the penetration of anti-cancer platinum complexes into spheroid tumour models.
Topics: Anthraquinones; Cell Line, Tumor; Cisplatin; Colonic Neoplasms; Electricity; Female; Formaldehyde; H | 2012 |
Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phase.
Topics: Biomarkers, Tumor; Biopsy; Blotting, Western; Chromatography, Liquid; Cold Ischemia; Colon; Colonic | 2012 |
BCA-225 immunostain: is it of value in liver fine needle aspiration?
Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy, Needle; Carcinoma, Hepatocellular; Carcinoma, Neuroendocr | 2002 |
[TRIAL TREATMENT OF CANCER].
Topics: Carcinoma; Carcinoma, Squamous Cell; Colonic Neoplasms; Facial Neoplasms; Female; Formaldehyde; Geni | 1963 |
Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays.
Topics: Algorithms; Breast; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Colon; Colonic Neoplasms; | 2004 |
Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis.
Topics: Adenocarcinoma; Breast Neoplasms; Colonic Neoplasms; Female; Fixatives; Formaldehyde; Gene Expressio | 2004 |
Antiprimer quenching-based real-time PCR and its application to the analysis of clinical cancer samples.
Topics: Apolipoproteins B; Breast Neoplasms; Colonic Neoplasms; DNA; DNA Primers; Female; Fixatives; Fluores | 2006 |
Liquid Tissue: proteomic profiling of formalin-fixed tissues.
Topics: Chromatography, Liquid; Colonic Neoplasms; Formaldehyde; Humans; Mass Spectrometry; Neoplasm Protein | 2005 |
A novel fixative improves opportunities of nucleic acids and proteomic analysis in human archive's tissues.
Topics: Base Sequence; Blotting, Western; Colonic Neoplasms; DNA Primers; DNA, Neoplasm; Electrophoresis, Ge | 2006 |
Combination of FTIR spectral imaging and chemometrics for tumour detection from paraffin-embedded biopsies.
Topics: Biomarkers, Tumor; Biopsy; Colonic Neoplasms; Fixatives; Formaldehyde; Humans; Neoplasms; Paraffin; | 2008 |
Development of an all-in-one technology for glycan profiling targeting formalin-embedded tissue sections.
Topics: Adenocarcinoma; Biomarkers; Cell Line, Tumor; Colonic Neoplasms; Dissection; Formaldehyde; Humans; L | 2008 |
Cancer mortality among workers exposed to formaldehyde.
Topics: Aged; Cheek; Chemical Industry; Colonic Neoplasms; Formaldehyde; Humans; Male; Massachusetts; Middle | 1984 |
Mortality patterns among embalmers.
Topics: Adult; Age Factors; Aged; Colonic Neoplasms; Coronary Disease; Embalming; Formaldehyde; Humans; Lung | 1983 |
Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; Formaldehyde; Histocy | 1994 |
Methods in pathology. p53 expression in formalin-fixed, paraffin-embedded archival specimens of intrahepatic cholangiocarcinoma: retrieval of p53 antigenicity by microwave oven heating of tissue sections.
Topics: Antibodies, Monoclonal; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma; Cholangiocarcinoma | 1994 |
An immunohistochemical study of the expression of p53 protein in colon cancer.
Topics: Adenocarcinoma; Adenoma; Adult; Biomarkers, Tumor; Colonic Neoplasms; Female; Formaldehyde; Humans; | 1995 |
A new monoclonal antibody for specific immunocytochemical staining of nucleoli.
Topics: Animals; Antibodies, Monoclonal; Caco-2 Cells; Cell Nucleolus; Colonic Neoplasms; Deoxyribonucleases | 1996 |
Modified formalin and methanol fixation methods for molecular biological and morphological analyses.
Topics: Breast; Breast Neoplasms; Colon; Colonic Neoplasms; DNA; Fixatives; Formaldehyde; Gastric Mucosa; Hu | 1997 |
Quantitative comparison of immunohistochemical staining intensity in tissues fixed in formalin and Histochoice.
Topics: Analysis of Variance; Antigens, CD20; Carcinoma; Chromogranins; Colonic Neoplasms; Factor VIII; Fixa | 1997 |
The pathologic measurement of polyp size is preferable to the endoscopic estimate.
Topics: Adenomatous Polyps; Colon; Colonic Neoplasms; Colonic Polyps; Colonoscopy; Female; Formaldehyde; Hum | 1997 |
Amplification of fluorescent in situ hybridisation signals in formalin fixed paraffin wax embedded sections of colon tumour using biotinylated tyramide.
Topics: Biotin; Chromosome Aberrations; Chromosomes, Human, Pair 9; Colonic Neoplasms; Formaldehyde; Humans; | 1997 |
Determination of endogenous formaldehyde in plants (fruits) bound to L-arginine and its relation to the folate cycle, photosynthesis and apoptosis.
Topics: Adenocarcinoma; Apoptosis; Arginine; Chromatography, High Pressure Liquid; Colonic Neoplasms; Folic | 1998 |
Automated immunohistochemical staining of formalin-fixed and paraffin-embedded tissues using a catalyzed signal amplification method.
Topics: Antigens; Breast Neoplasms; Colonic Neoplasms; Fixatives; Formaldehyde; Humans; Immunohistochemistry | 2001 |
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Topics: Acetylation; Antimetabolites, Antineoplastic; Azacitidine; Chromatin; Colonic Neoplasms; CpG Islands | 2001 |
Non-disruptive PNA-FISH protocol for formalin-fixed and paraffin-embedded tissue sections.
Topics: Animals; Cell Nucleus; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Colonic Neoplasms; D | 2001 |
Organ-specific effects of the carcinogen methylazoxymethanol related to metabolism by nicotinamide adenine dinucleotide-dependent dehydrogenases.
Topics: Alcohol Oxidoreductases; Animals; Azo Compounds; Colon; Colonic Neoplasms; Formaldehyde; In Vitro Te | 1977 |
Detection of BLT substrate-specific proteases in individual human peripheral blood leucocytes and bone marrow cells. Application of the method to the classification of leukaemia.
Topics: Antibodies, Monoclonal; Bone Marrow; Colonic Neoplasms; Diazonium Compounds; Formaldehyde; Granulocy | 1991 |
Southern and dot blot analysis of DNA from formalin-fixed, paraffin-embedded tissue samples from colonic carcinomas.
Topics: Blotting, Southern; Colonic Neoplasms; Densitometry; DNA Probes; DNA, Neoplasm; Electrophoresis, Aga | 1990 |
Reactivity of monoclonal antibody (mAb) GD9 with a cytoplasmic antigen preserved in formalin-fixed, paraffin-embedded gastrointestinal tumors.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antigens, Neoplasm; Col | 1991 |
The inhibition of a tumour cell surface protease in vivo and its re-activation by oxidation.
Topics: Aminacrine; Carboxylic Ester Hydrolases; Colonic Neoplasms; Endopeptidases; Enzyme Reactivators; For | 1988 |
Flow cytometric DNA analysis of colon adenocarcinomas: a comparative study of preparatory techniques.
Topics: Adenocarcinoma; Animals; Cell Line; Colonic Neoplasms; DNA; Ethanol; Flow Cytometry; Formaldehyde; H | 1988 |
Effects of several commonly used fixatives on DNA and total nuclear protein analysis by flow cytometry.
Topics: Adenocarcinoma; Breast Neoplasms; Carcinoma, Squamous Cell; Colonic Neoplasms; DNA; Fixatives; Flow | 1989 |
Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.
Topics: Carcinoma; Colonic Neoplasms; DNA; DNA Restriction Enzymes; DNA, Neoplasm; Fixatives; Formaldehyde; | 1985 |
[Prevention by formol administration of anastomosis recurrence].
Topics: Animals; Colonic Neoplasms; Formaldehyde; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplastic C | 1971 |